文献速递炎症性肠病

胎儿期及婴儿期抗生素暴露与极早发型炎症性肠病:一项基于人群的研究

Fetal and early life antibiotics exposure and very early onset inflammatory bowel disease: a population-based study.
PubMed 文献 · Gut · 2018-01-10

该研究基于瑞典2006至2013年出生的827239名儿童,采用Cox比例风险回归分析孕期或婴儿期全身抗生素暴露与6岁前诊断的极早发型炎症性肠病(VEO-IBD)的关联。结果显示孕期抗生素暴露与IBD风险升高相关(aHR 1.93,95%CI 1.06-3.50),婴儿期暴露则无显著关联。

要点

  • 孕期抗生素暴露与VEO-IBD风险升高相关(aHR 1.93,95%CI 1.06-3.50)。
  • 婴儿期抗生素暴露与VEO-IBD风险无显著关联(aHR 1.11,95%CI 0.57-2.15)。
  • 排除胃肠炎后孕期抗生素与IBD关联不再显著,但与克罗恩病关联仍相似。

核心结论

  • 孕期而非婴儿期抗生素暴露与VEO-IBD风险升高相关,且该关联不受胃肠炎影响。
  • 孕期抗生素暴露的风险升高可能源于微生物群改变。

研究设计与样本

  • 基于瑞典2006至2013年出生的827239名儿童的队列研究。
  • 采用Cox比例风险回归模型,数据来自瑞典处方药登记和国家患者登记。
  • VEO-IBD定义为6岁前诊断,并特别考察了父母IBD和胃肠炎的潜在混杂。

主要发现

  • 孕期抗生素暴露与IBD风险升高相关(aHR 1.93,95%CI 1.06-3.50)。
  • 孕期抗生素暴露与克罗恩病风险升高相关(aHR 2.48,95%CI 1.01-6.08)。
  • 孕期抗生素暴露与溃疡性结肠炎风险无显著关联(aHR 1.25,95%CI 0.47-3.26)。
  • 婴儿期抗生素暴露与IBD风险无显著关联(aHR 1.11,95%CI 0.57-2.15),与克罗恩病(aHR 0.72,95%CI 0.27-1.92)和溃疡性结肠炎(aHR 1.23,95%CI 0.45-3.39)亦无显著关联。
  • 排除首次IBD诊断前12个月内患胃肠炎的儿童后,孕期抗生素与克罗恩病的aHR相似,但与IBD的关联不再显著。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Earlier studies on antibiotics exposure and development of IBD (Crohn's disease (CD) and ulcerative colitis (UC)) may have been biased by familial factors and gastroenteritis. We aimed to estimate the association between antibiotics during pregnancy or infantile age and very early onset (VEO) IBD. DESIGN: In this cohort study of 827 239 children born in Sweden between 2006 and 2013, we examined the link between exposure to systemic antibiotics and VEO-IBD (diagnosis <6 years of age), using Cox proportional hazard regression models. Information on antibiotics and IBD was retrieved from the nationwide population-based Swedish Prescribed Drug Register and the National Patient Register. We specifically examined potential confounding from parental IBD and gastroenteritis. RESULTS: Children exposed to antibiotics during pregnancy were at increased risk of IBD compared with general population controls (adjusted HR (aHR) 1.93; 95% CI 1.06 to 3.50). Corresponding aHRs were 2.48 (95% CI 1.01 to 6.08) for CD and 1.25 (95% CI 0.47 to 3.26) for UC, respectively. For antibiotics in infantile age, the aHR for IBD was 1.11 (95% CI 0.57 to 2.15); for CD 0.72 (95% CI 0.27 to 1.92) and 1.23 (95% CI 0.45 to 3.39) for UC. Excluding children with gastroenteritis 12 months prior to the first IBD diagnosis retained similar aHR for antibiotics during pregnancy and CD, while the association no longer remained significant for IBD. CONCLUSION: We found that exposure to antibiotics during pregnancy, but not in infantile age, is associated with an increased risk of VEO-IBD regardless of gastroenteritis. The risk increase for exposure in pregnancy may be due to changes in the microbiota.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Örtqvist AK, Lundholm C, Halfvarson J, et al. Fetal and early life antibiotics exposure and very early onset inflammatory bowel disease: a population-based study. Gut. 2018. PMID: 29321166. doi:10.1136/gutjnl-2017-314352

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。